Pacific Biosciences of California, Inc.
PACB
$1.37
-$0.01-0.73%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -128.58M | -546.38M | -503.63M | -526.36M | -657.75M |
| Total Depreciation and Amortization | 17.70M | 386.41M | 392.71M | 404.41M | 414.12M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.97M | 44.31M | -17.18M | -12.44M | 86.82M |
| Change in Net Operating Assets | 10.00M | 4.44M | 5.32M | -15.16M | -17.62M |
| Cash from Operations | -111.84M | -111.21M | -122.79M | -149.55M | -174.43M |
| Capital Expenditure | -4.37M | -2.71M | -3.47M | -2.77M | -3.70M |
| Sale of Property, Plant, and Equipment | 50.00M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.44M | 118.16M | 151.13M | 154.59M | 207.07M |
| Cash from Investing | 106.07M | 115.45M | 147.66M | 151.82M | 203.37M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -50.20M | -50.20M | -50.35M |
| Issuance of Common Stock | 2.91M | 3.43M | 3.43M | 2.77M | 2.77M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.91M | 3.43M | -46.77M | -47.43M | -47.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.87M | 7.67M | -21.91M | -45.16M | -18.64M |